FC
ABBV icon

Financial Consulate’s AbbVie ABBV Stock Holding History

Financial Consulate’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$797K Buy
3,167
+98
+3% +$21.1K 0.09% 66
2026
Q1 		$667K Buy
3,069
+61
+2% +$13.5K 0.08% 68
2025
Q4 		$687K Sell
3,008
-151
-5% -$34.4K 0.09% 68
2025
Q3 		$731K Buy
+3,159
New +$643K 0.1% 67
2023
Q2 		– Sell
-2,514
Closed -$401K – 42
2023
Q1 		$401K Buy
2,514
+35
+1% +$5.35K 0.14% 85
2022
Q4 		$401K Sell
2,479
-999
-29% -$153K 0.14% 90
2022
Q3 		$467K Buy
3,478
+2
+0.1% +$287 0.2% 59
2022
Q2 		$532K Buy
3,476
+1
+0% +$153 0.25% 53
2022
Q1 		$563K Buy
3,475
+181
+5% +$26.3K 0.22% 60
2021
Q4 		$446K Buy
3,294
+1
+0% +$118 0.15% 82
2021
Q3 		$355K Buy
3,293
+1,002
+44% +$114K 0.13% 87
2021
Q2 		$258K Buy
2,291
+26
+1% +$2.93K 0.09% 106
2021
Q1 		$245K Buy
2,265
+2
+0.1% +$214 0.1% 98
2020
Q4 		$243K Buy
+2,263
New +$217K 0.1% 93

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Financial Consulate's ABBV Position: Q2 2026 in Review

Financial Consulate increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $21.1K and bringing the position to 3,167 shares worth $797K. The position accounts for 0.09% of the portfolio, ranked #66.

Financial Consulate first reported a position in ABBV in Q4 2020 and has held it in 14 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Financial Consulate held 3,167 shares of AbbVie worth $797K as of Q2 2026.
  • Financial Consulate bought 98 AbbVie shares in Q2 2026, an estimated $21.1K.
  • AbbVie made up 0.09% of Financial Consulate's portfolio in Q2 2026, its #66 holding.
  • Financial Consulate first reported a position in AbbVie in Q4 2020 and has held it in 14 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.